304 related articles for article (PubMed ID: 26036346)
1. Micro-RNAs miR-29a and miR-330-5p function as tumor suppressors by targeting the MUC1 mucin in pancreatic cancer cells.
Tréhoux S; Lahdaoui F; Delpu Y; Renaud F; Leteurtre E; Torrisani J; Jonckheere N; Van Seuningen I
Biochim Biophys Acta; 2015 Oct; 1853(10 Pt A):2392-403. PubMed ID: 26036346
[TBL] [Abstract][Full Text] [Related]
2. The MUC1 oncomucin regulates pancreatic cancer cell biological properties and chemoresistance. Implication of p42-44 MAPK, Akt, Bcl-2 and MMP13 pathways.
Tréhoux S; Duchêne B; Jonckheere N; Van Seuningen I
Biochem Biophys Res Commun; 2015 Jan; 456(3):757-62. PubMed ID: 25511698
[TBL] [Abstract][Full Text] [Related]
3. Downregulated miR-98-5p promotes PDAC proliferation and metastasis by reversely regulating MAP4K4.
Fu Y; Liu X; Chen Q; Liu T; Lu C; Yu J; Miao Y; Wei J
J Exp Clin Cancer Res; 2018 Jul; 37(1):130. PubMed ID: 29970191
[TBL] [Abstract][Full Text] [Related]
4. miR-219-1-3p is a negative regulator of the mucin MUC4 expression and is a tumor suppressor in pancreatic cancer.
Lahdaoui F; Delpu Y; Vincent A; Renaud F; Messager M; Duchêne B; Leteurtre E; Mariette C; Torrisani J; Jonckheere N; Van Seuningen I
Oncogene; 2015 Feb; 34(6):780-8. PubMed ID: 24608432
[TBL] [Abstract][Full Text] [Related]
5. Targeting the Highly Expressed microRNA miR-146b with CRISPR/Cas9n Gene Editing System in Thyroid Cancer.
Santa-Inez DC; Fuziwara CS; Saito KC; Kimura ET
Int J Mol Sci; 2021 Jul; 22(15):. PubMed ID: 34360757
[TBL] [Abstract][Full Text] [Related]
6. miR-485-5p inhibits the progression of breast cancer cells by negatively regulating MUC1.
Wang X; Zhou X; Zeng F; Wu X; Li H
Breast Cancer; 2020 Jul; 27(4):765-775. PubMed ID: 32144736
[TBL] [Abstract][Full Text] [Related]
7. MiR-140-5p inhibits cell proliferation and metastasis by regulating MUC1 via BCL2A1/MAPK pathway in triple negative breast cancer.
Yu B; You W; Chen G; Yu Y; Yang Q
Cell Cycle; 2019 Oct; 18(20):2641-2650. PubMed ID: 31411515
[TBL] [Abstract][Full Text] [Related]
8. MiR-345-5p functions as a tumor suppressor in pancreatic cancer by directly targeting CCL8.
Mou T; Xie F; Zhong P; Hua H; Lai L; Yang Q; Wang J
Biomed Pharmacother; 2019 Mar; 111():891-900. PubMed ID: 30841468
[TBL] [Abstract][Full Text] [Related]
9. MiRNA-615-5p functions as a tumor suppressor in pancreatic ductal adenocarcinoma by targeting AKT2.
Sun Y; Zhang T; Wang C; Jin X; Jia C; Yu S; Chen J
PLoS One; 2015; 10(4):e0119783. PubMed ID: 25856297
[TBL] [Abstract][Full Text] [Related]
10. A miR-146a-5p/TRAF6/NF-kB p65 axis regulates pancreatic cancer chemoresistance: functional validation and clinical significance.
Meng Q; Liang C; Hua J; Zhang B; Liu J; Zhang Y; Wei M; Yu X; Xu J; Shi S
Theranostics; 2020; 10(9):3967-3979. PubMed ID: 32226532
[No Abstract] [Full Text] [Related]
11. MiR-371-5p facilitates pancreatic cancer cell proliferation and decreases patient survival.
He D; Miao H; Xu Y; Xiong L; Wang Y; Xiang H; Zhang H; Zhang Z
PLoS One; 2014; 9(11):e112930. PubMed ID: 25411783
[TBL] [Abstract][Full Text] [Related]
12. Nicotine promotes tumor progression and epithelial-mesenchymal transition by regulating the miR-155-5p/NDFIP1 axis in pancreatic ductal adenocarcinoma.
Ben Q; Sun Y; Liu J; Wang W; Zou D; Yuan Y
Pancreatology; 2020 Jun; 20(4):698-708. PubMed ID: 32354626
[TBL] [Abstract][Full Text] [Related]
13. Expression of KL-6/MUC1 in pancreatic cancer tissues and its potential involvement in tumor metastasis.
Xu H; Inagaki Y; Seyama Y; Du G; Wang F; Kokudo N; Tang W
Oncol Rep; 2011 Aug; 26(2):371-6. PubMed ID: 21617869
[TBL] [Abstract][Full Text] [Related]
14. Elevation of microRNA-512-5p inhibits MUC1 to reduce radioresistance in cervical cancer.
Zhang J; Wang L; Jiang J; Qiao Z
Cell Cycle; 2020 Mar; 19(6):652-665. PubMed ID: 32126879
[TBL] [Abstract][Full Text] [Related]
15. CDX2 inhibits pancreatic adenocarcinoma cell proliferation via promoting tumor suppressor miR-615-5p.
Jiang Y; Zhang Y; Li F; Du X; Zhang J
Tumour Biol; 2016 Jan; 37(1):1041-9. PubMed ID: 26269116
[TBL] [Abstract][Full Text] [Related]
16. ANLN-induced EZH2 upregulation promotes pancreatic cancer progression by mediating miR-218-5p/LASP1 signaling axis.
Wang A; Dai H; Gong Y; Zhang C; Shu J; Luo Y; Jiang Y; Liu W; Bie P
J Exp Clin Cancer Res; 2019 Aug; 38(1):347. PubMed ID: 31395079
[TBL] [Abstract][Full Text] [Related]
17. MiR-145 is downregulated in human ovarian cancer and modulates cell growth and invasion by targeting p70S6K1 and MUC1.
Wu H; Xiao Z; Wang K; Liu W; Hao Q
Biochem Biophys Res Commun; 2013 Nov; 441(4):693-700. PubMed ID: 24157791
[TBL] [Abstract][Full Text] [Related]
18. Molecular pathogenesis of pancreatic ductal adenocarcinoma: Impact of passenger strand of pre-miR-148a on gene regulation.
Idichi T; Seki N; Kurahara H; Fukuhisa H; Toda H; Shimonosono M; Okato A; Arai T; Kita Y; Mataki Y; Kijima Y; Maemura K; Natsugoe S
Cancer Sci; 2018 Jun; 109(6):2013-2026. PubMed ID: 29660218
[TBL] [Abstract][Full Text] [Related]
19. miR-9-5p inhibits pancreatic cancer cell proliferation, invasion and glutamine metabolism by targeting GOT1.
Wang J; Wang B; Ren H; Chen W
Biochem Biophys Res Commun; 2019 Jan; 509(1):241-248. PubMed ID: 30591220
[TBL] [Abstract][Full Text] [Related]
20. Novel miR-5582-5p functions as a tumor suppressor by inducing apoptosis and cell cycle arrest in cancer cells through direct targeting of GAB1, SHC1, and CDK2.
An HJ; Kwak SY; Yoo JO; Kim JS; Bae IH; Park MJ; Cho MY; Kim J; Han YH
Biochim Biophys Acta; 2016 Oct; 1862(10):1926-37. PubMed ID: 27475256
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]